Fulgent Genetics Inc (FLGT)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 283,470 277,761 290,705 287,530 289,213 286,412 307,380 364,868 618,968 802,935 925,148 953,423 992,584 1,035,891 909,739 773,388 421,712 135,121 43,752 34,911
Receivables US$ in thousands — — — — — — — — — — — — — — — — — — — —
Receivables turnover — — — — — — — — — — — — — — — — — — — —

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $283,470K ÷ $—K
= —

The data provided for Fulgent Genetics Inc's receivables turnover shows that the ratio was not available for analysis for the periods from March 31, 2020, to December 31, 2024.

Receivables turnover is a financial ratio that measures how efficiently a company is managing its receivables by indicating how many times during a period the company collects its average receivables balance. A higher receivables turnover ratio generally indicates that a company is collecting its accounts receivable more efficiently.

Due to the lack of specific data points to analyze, it is not possible to assess Fulgent Genetics Inc's receivables turnover performance over the specified period. It is crucial for the company to provide this information in order to evaluate its effectiveness in converting its credit sales into cash efficiently.

In the absence of this data, it is recommended that Fulgent Genetics Inc periodically disclose its receivables turnover ratio to enable stakeholders and analysts to make informed decisions regarding the company's financial management and operational efficiency.